Shares of Tandem Diabetes Care, Inc. (TNDM), an insulin delivery and diabetes technology company, are rising more than 7% Tuesday morning after the company said it received clearance from the FDA for its Tandem Mobi insulin pump for people aged 6 and more.
The Tandem Mobi, which can be fully controlled from a mobile app, is the world's smallest durable automated insulin delivery system, the company said.
TNDM is at $26.78 currently. It has traded in the range of $23.60 - $70.81 in the last 1 year.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.